Seven-phase Microsoft enterprise project management methodology with senior-architect bench, named artifacts at every ...

FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September 18, 2026 NDA submission for neladalkib in TKI ...

‘We are on the journey to get to the operating model,’ says Cognizant CEO Ravi Kumar S. Cognizant plans to spend upward of $270 million on employee severance and other personnel-related costs as part ...